KINARUS THERAPEUTICS HOLDING AG
Share · CH0009115129 · 928449 (XSWX)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of KINARUS THERAPEUTICS HOLDING AG
No Price
Company Profile for KINARUS THERAPEUTICS HOLDING AG Share
Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.
Company Data
Name KINARUS THERAPEUTICS HOLDING AG
Company Kinarus Therapeutics Holding AG
Website
https://www.kinarus.com
Primary Exchange 
SIX
SIX
WKN 928449
ISIN CH0009115129
Asset Class Share
Sector Industrials
Industry Airlines, Airports & Air Services
CEO Jean-Claude Roch
Country Switzerland
Currency CHF
Employees 0,0 T
Address Avenue de Florimont 3, 1006 Lausanne
IPO Date 1999-10-18
Ticker Symbols
| Name | Symbol |
|---|---|
| SIX | PRFN.SW |
More Shares
Investors who hold KINARUS THERAPEUTICS HOLDING AG also have the following shares in their portfolio:
